×
App Icon
The Standard e-Paper
Truth Without Fear
★★★★ - on Play Store
Download Now

Drug that shortens recovery time for Covid-19 patients to be availed in Kenya

Indian firm Cipla will distribute remdesivir in Kenya, an antiviral drug that could be critical in the management of Covid-19.

Cipla entered into an agreement with America’s Gilead Sciences, which owns the patent for the drug, granting it a licence to manufacture and distribute the drug in 127 countries, including Kenya.

Get Full Access for Ksh299/Week
Bold Reporting Takes Time, Courage and Investment. Stand With Us.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in